Selective iGluR5 receptor antagonists for the treatment of migraine
A Standard patent application filed on 27 June 2000 credited to Bleakman, David
;
Chappell, Amy Suzon
;
Ornstein, Paul Leslie
;
Johnson, Kirk Willis
;
Filla, Sandra Ann
Details
Application number :
58732
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Selective iGluR5 receptor antagonists for the treatment of migraine
Inventor :
Bleakman, David
;
Chappell, Amy Suzon
;
Ornstein, Paul Leslie
;
Johnson, Kirk Willis
;
Filla, Sandra Ann
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
27 June 2000
Associated companies :
Applicant name :
Eli Lilly and Company
Applicant address :
Lilly Corporate Center Indianapolis IN 46285 United States Of America